Public Release: 

29th ECNP Congress for Applied and Translational Neuroscience

European College of Neuropsychopharmacology

Europe's largest meeting in applied and translational neuroscience, the 29th ECNP Congress of the European College of Neuropsychopharmacology (ECNP) will take place at the Austria Center Vienna from 17th to 20th September 2016. Between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists are expected to attend the Vienna congress.

The 2015 ECNP congress produced some major press stories (see https://www.ecnp.eu/about-ecnp/press.aspx). The 2016 congress will include sessions on:

  • Psychedelics and brain function
  • Sleep disorders
  • How stress affects the body
  • Can we slow Alzheimer's Disease?
  • How children's psychology differs from that of adults

Journalists are welcome to attend the conference, and can register at: http://www.ecnp-congress.eu/registrationhotel/press-registration.aspx

Journalists who cannot attend can still receive advance press releases, by contacting press@ecnp.eu. During the Congress, you can reach the ECNP press officer, Tom Parkhill, on the above email or via +39 349 238 8191.

The congress website is: http://www.ecnp-congress.eu.

###

ECNP is an independent scientific association committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health. The annual ECNP Congress attracts scientists and clinicians from across the world to discuss the latest advances in brain research at Europe's premier showcase for new research, treatment and technology in applied brain research. More information about ECNP, its aims and activities, can be found at http://www.ecnp.eu.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.